Evidence map›Paper›PMID 42396218›Full record

ReviewPublic health challenges2026

Beyond the Battlefield: Examining Acute Kidney Injury in Yemen's Humanitarian Crisis.

Gamal Esam Ahmed Alsakkaf

Abstract readReview
In one paragraph

Review in Public health challenges, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gamal Esam Ahmed AlsakkafDepartment of Clinical Pharmacy, Faculty of Pharmacy Near East University Nicosia North Cyprus Cyprus.ORCID https://orcid.org/0000-0001-8906-3873

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute kidney injury (AKI) represents a growing yet under-recognized public health threat in Yemen, where ongoing conflict has exacerbated vulnerabilities to infectious diseases and waterborne illnesses. Sepsis and severe volume depletion-secondary to diarrheal diseases such as cholera-are leading contributors to AKI incidence, especially in a region with a collapsing health infrastructure and limited access to dialysis. Objective: This review consolidates existing evidence on the burden, causes, and outcomes of infection-related and dehydration-induced AKI in Yemen. It emphasizes systemic gaps in surveillance, diagnostic capacity, and treatment and suggests practical interventions for low-resource, conflict-affected settings. Methods: This narrative review conducted a structured search of international databases and gray literature, including sources from humanitarian agencies and regional health authorities. Studies reporting on AKI incidence, etiologies, and healthcare access in Yemen from 2014 to 2024 were included. Results: The data indicate a disproportionate burden of AKI among children and internally displaced populations within cholera-endemic governorates. Shortages of dialysis resources, delayed diagnoses, and underreporting collectively worsen mortality risks. Most documented AKI cases are associated with hypovolemia, systemic infections, and a deficiency in preventive measures. Conclusion: Infection-driven and dehydration-related AKI are critical yet preventable causes of morbidity and mortality in Yemen. Integrating AKI prevention into diarrheal disease programs, scaling up oral rehydration and sepsis management, and strengthening community health systems are essential to mitigating renal complications and saving lives.

Indexed as

acute kidney injurycholerahumanitarian crisismalariarenal replacement therapyYemen

Identifiers

PMID42396218
PMCPMC13325548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.